See the DrugPatentWatch profile for polivy

Polivy, also known as polatuzumab vedotin, is a medication used to treat certain types of blood cancer. It is a type of drug known as an antibody-drug conjugate, which means it combines an antibody that targets cancer cells with a chemotherapy drug. This allows the chemotherapy to be delivered directly to the cancer cells.

There are several common reactions that can occur in people taking Polivy. These include:

* Nausea and vomiting
* Fatigue
* Constipation
* Hair loss
* Decreased appetite
* Peripheral neuropathy (numbness, tingling, or pain in the hands and feet)
* Diarrhea
* Pyrexia (fever)
* Increased risk of infection

It is important for patients to report any side effects they experience to their healthcare provider. In some cases, these side effects may be managed with medication or by adjusting the dose of Polivy.

It is also important to note that Polivy can cause serious side effects, such as liver problems and infusion reactions. Patients should be monitored closely for these side effects while taking Polivy.

For more information about Polivy and its side effects, please see the drug label at [DrugPatentWatch.com](https://www.drugpatentwatch.com/drugs/polivy).

Sources:

1. DrugPatentWatch.com. Polivy. <https://www.drugpatentwatch.com/drugs/polivy>.